[1]
“Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease”, GJMR, vol. 25, no. A1, pp. 1–7, Jan. 2026, doi: 10.34257/GJMRAVOL25IS1PG1.